Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.

Journal: Frontiers in immunology
Published Date:

Abstract

BACKGROUND: Lung adenocarcinoma (LUAD) is a heterogeneous tumor characterized by diverse genetic and molecular alterations. Developing a multi-omics-based classification system for LUAD is urgently needed to advance biological understanding.

Authors

  • Yi Zhang
    Department of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin University, Changchun, China.
  • Yuzhi Wang
    Department of Laboratory Medicine, Deyang People's Hospital, Deyang, Sichuan, China.
  • Haitao Qian
    Department of Anesthesiology, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China.